論文・総説 - 吉田　雅幸

81. Shunsuke Ito, Masayuki Yoshida. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients. Toxins (Basel). 2014.02; 6 (2): 665-678. ( PubMed, DOI )

82. Yuya Matsue, Kazuki Yoshida, Wataru Nagahori, Masakazu Ohno, Makoto Suzuki, Akihiko Matsumura, Yuji Hashimoto, Masayuki Yoshida. Peripheral microvascular dysfunction predicts residual risk in coronary artery disease patients on statin therapy. Atherosclerosis. 2014.01; 232 (1): 186-190. ( PubMed, DOI )

83. Katsuhiko Hamada, Mizuko Osaka, Masayuki Yoshida. Cell density impacts epigenetic regulation of cytokine-induced E-selectin gene expression in vascular endothelium. PLoS ONE. 2014; 9 (4): e90502. ( PubMed, DOI )

84. Eiichiro Kanda, Masumi Ai, Renjiro Kuriyama, Masayuki Yoshida, Tatsuo Shiigai. Dietary acid intake and kidney disease progression in the elderly. Am. J. Nephrol.. 2014; 39 (2): 145-152. ( PubMed, DOI )

85. Hiroyoshi Yokoi, Ryuji Nohara, Hiroyuki Daida, Mitsumasa Hata, Kohei Kaku, Ryuzo Kawamori, Junji Kishimoto, Masahiko Kurabayashi, Izuru Masuda, Ichiro Sakuma, Tsutomu Yamazaki, Masayuki Yoshida. Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART study. Int Heart J. 2014; 55 (2): 146-152. ( PubMed )

86. Ito S, Higuchi Y, Yagi Y, Nishijima F, Yamato H, Ishii H, Osaka M, Yoshida M. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. J Leukoc Biol. 2013.06; 93 (6): 837-845. ( PubMed, DOI )

87. Eiichiro Kanda, Masumi Ai, Asami Iwamoto, Mitsuyo Okazaki, Yoshitaka Maeda, Sei Sasaki, Masayuki Yoshida. Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography. BMC Nephrol. 2013; 14 234. ( PubMed, DOI )

88. Yamazaki Tsutomu, Nohara Ryuji, Daida Hiroyuki, Hata Mitsumasa, Kaku Kohei, Kawamori Ryuzo, Kishimoto Junji, Kurabayashi Masahiko, Masuda Izuru, Sakuma Ichiro, Yokoi Hiroyoshi, Yoshida Masayuki. Intensive Lipid-Lowering Therapy for Slowing Progression as Well as Inducing Regression of Atherosclerosis in Japanese Patients: Subanalysis of the JART Study International Heart Journal. 2013; 54 (1): 33-39. ( 医中誌 )

89. Osaka M, Hagita S, Yoshida M. In vivo imaging of leukocyte recruitment to the atheroprone femoral artery reveals anti-inflammatory effects of rosuvastatin. Biomed Res Int. 2013; 2013 962369. ( PubMed, DOI )

90. Ryuji Nohara, Hiroyuki Daida, Mitsumasa Hata, Kohei Kaku, Ryuzo Kawamori, Junji Kishimoto, Masahiko Kurabayashi, Izuru Masuda, Ichiro Sakuma, Tsutomu Yamazaki, Hiroyoshi Yokoi, Masayuki Yoshida, . Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study. Circ. J.. 2013; 77 (6): 1526-1533. ( PubMed )

91. Eiichiro Kanda, Masumi Ai, Masayuki Yoshida, Renjiro Kuriyama, Tatsuo Shiigai. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients. BMC Nephrol. 2013; 14 4. ( PubMed, DOI )

92. Eiichiro Kanda, Masumi Ai, Mitsuyo Okazaki, Yoshitaka Maeda, Sei Sasaki, Masayuki Yoshida. The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level. BMC Nephrol. 2013; 14 212. ( PubMed, DOI )

93. Matsue Y, Suzuki M, Nagahori W, Ohno M, Matsumura A, Hashimoto Y, Yoshida K, Yoshida M. Endothelial dysfunction measured by peripheral arterial tonometry predicts prognosis in patients with heart failure with preserved ejection fraction. Int J Cardiol. 2012.09; ( PubMed, DOI )

94. Ishii H, Yoshida M. [Blood lipid measurement]. Nihon Rinsho. 2012.05; 70 Suppl 3 455-458. ( PubMed )

95. Gomita Keiko, Sato Kayoko, Yoshida Masayuki, Hagiwara Nobuhisa. PSGL-1-Expressing CD4 T Cells Induce Endothelial Cell Apoptosis in Perimenopausal Women Journal of Atherosclerosis and Thrombosis. 2012; 19 (3): 227-236. ( 医中誌 )

96. Gomita K, Sato K, Yoshida M, Hagiwara N. PSGL-1-expressing CD4 T cells induce endothelial cell apoptosis in perimenopausal women. J Atheroscler Thromb. 2012; 19 (3): 227-236. ( PubMed )

97. Ryuji Nohara, Hiroyuki Daida, Mitsumasa Hata, Kohei Kaku, Ryuzo Kawamori, Junji Kishimoto, Masahiko Kurabayashi, Izuru Masuda, Ichiro Sakuma, Tsutomu Yamazaki, Hiroyoshi Yokoi, Masayuki Yoshida, . Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study. Circ. J.. 2012; 76 (1): 221-229. ( PubMed )

98. Eiichiro Kanda, Masayuki Yoshida, Sei Sasaki. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients. BMC Nephrol. 2012; 13 122. ( PubMed, DOI )

99. Kuwahara H, Nishina K, Yoshida K, Nishina T, Yamamoto M, Saito Y, Piao W, Yoshida M, Mizusawa H, Yokota T. Efficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoprotein. Mol Ther. 2011.12; 19 (12): 2213-2221. ( PubMed, DOI )

100. Hagita S, Osaka M, Shimokado K, Yoshida M. Combination of amlodipine and atorvastatin synergistically reduces leukocyte recruitment to mechanically injured mouse femoral artery. Hypertens Res. 2011.04; 34 (4): 450-455. ( PubMed, DOI )